134 related articles for article (PubMed ID: 34298105)
1. Fabrication of amphotericin B-loaded electrospun core-shell nanofibers as a novel dressing for superficial mycoses and cutaneous leishmaniasis.
Asgari Q; Alishahi M; Davani F; Caravan D; Khorram M; Enjavi Y; Barzegar S; Esfandiari F; Zomorodian K
Int J Pharm; 2021 Sep; 606():120911. PubMed ID: 34298105
[TBL] [Abstract][Full Text] [Related]
2. Glucantime-loaded electrospun core-shell nanofibers composed of poly(ethylene oxide)/gelatin-poly(vinyl alcohol)/chitosan as dressing for cutaneous leishmaniasis.
Alishahi M; Khorram M; Asgari Q; Davani F; Goudarzi F; Emami A; Arastehfar A; Zomorodian K
Int J Biol Macromol; 2020 Nov; 163():288-297. PubMed ID: 32610052
[TBL] [Abstract][Full Text] [Related]
3. Dual drug delivery of vancomycin and imipenem/cilastatin by coaxial nanofibers for treatment of diabetic foot ulcer infections.
Davani F; Alishahi M; Sabzi M; Khorram M; Arastehfar A; Zomorodian K
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111975. PubMed ID: 33812603
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and antimicrobial properties of novel double layer nanocomposite electrospun fibers for wound dressing applications.
Hassiba AJ; El Zowalaty ME; Webster TJ; Abdullah AM; Nasrallah GK; Khalil KA; Luyt AS; Elzatahry AA
Int J Nanomedicine; 2017; 12():2205-2213. PubMed ID: 28356737
[TBL] [Abstract][Full Text] [Related]
5. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of electrospun poly(lactic acid)-chitosan core-shell nanofibers with a new solvent system.
Afshar S; Rashedi S; Nazockdast H; Ghazalian M
Int J Biol Macromol; 2019 Oct; 138():1130-1137. PubMed ID: 31299256
[TBL] [Abstract][Full Text] [Related]
7. Electrospinning of PVA/chitosan nanocomposite nanofibers containing gelatin nanoparticles as a dual drug delivery system.
Fathollahipour S; Abouei Mehrizi A; Ghaee A; Koosha M
J Biomed Mater Res A; 2015 Dec; 103(12):3852-62. PubMed ID: 26112829
[TBL] [Abstract][Full Text] [Related]
8. Wound dressing based on electrospun PVA/chitosan/starch nanofibrous mats: Fabrication, antibacterial and cytocompatibility evaluation and in vitro healing assay.
Adeli H; Khorasani MT; Parvazinia M
Int J Biol Macromol; 2019 Feb; 122():238-254. PubMed ID: 30342125
[TBL] [Abstract][Full Text] [Related]
9. Tetracycline hydrochloride-loaded electrospun nanofibers mats based on PVA and chitosan for wound dressing.
Alavarse AC; de Oliveira Silva FW; Colque JT; da Silva VM; Prieto T; Venancio EC; Bonvent JJ
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():271-281. PubMed ID: 28532030
[TBL] [Abstract][Full Text] [Related]
10. Magnetic chitosan nanoparticles loaded with Amphotericin B: Synthesis, properties and potentiation of antifungal activity against common human pathogenic fungal strains.
Zareshahrabadi Z; Khorram M; Pakshir K; Tamaddon AM; Jafari M; Nouraei H; Ardekani NT; Amirzadeh N; Irajie C; Barzegar A; Iraji A; Zomorodian K
Int J Biol Macromol; 2022 Dec; 222(Pt A):1619-1631. PubMed ID: 36183759
[TBL] [Abstract][Full Text] [Related]
11. Novel electrospun chitosan/polyvinyl alcohol/zinc oxide nanofibrous mats with antibacterial and antioxidant properties for diabetic wound healing.
Ahmed R; Tariq M; Ali I; Asghar R; Noorunnisa Khanam P; Augustine R; Hasan A
Int J Biol Macromol; 2018 Dec; 120(Pt A):385-393. PubMed ID: 30110603
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded liposome-incorporated chitosan (core)/poly(ε-caprolactone)/chitosan (shell) nanofibers for the treatment of breast cancer.
Hasanbegloo K; Banihashem S; Faraji Dizaji B; Bybordi S; Farrokh-Eslamlou N; Abadi PG; Jazi FS; Irani M
Int J Biol Macromol; 2023 Mar; 230():123380. PubMed ID: 36706885
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of
Anjum A; Shabbir K; Din FU; Shafique S; Zaidi SS; Almari AH; Alqahtani T; Maryiam A; Moneeb Khan M; Al Fatease A; Bashir S; Khan GM
Drug Deliv; 2023 Dec; 30(1):2173335. PubMed ID: 36722301
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Core-Shell Nanofibers Incorporating Amphotericin B by Solution Blow Spinning Against
Gonçalves IMF; Rocha ÍM; Pires EG; Muniz IAF; Maciel PP; de Lima JM; Dos Santos IMG; Batista RBD; de Medeiros ELG; de Medeiros ES; de Oliveira JE; Goulart LR; Bonan PRF; Castellano LRC
Front Bioeng Biotechnol; 2020; 8():571821. PubMed ID: 33195132
[TBL] [Abstract][Full Text] [Related]
16. Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice.
de Carvalho RF; Ribeiro IF; Miranda-Vilela AL; de Souza Filho J; Martins OP; Cintra e Silva Dde O; Tedesco AC; Lacava ZG; Báo SN; Sampaio RN
Exp Parasitol; 2013 Oct; 135(2):217-22. PubMed ID: 23891944
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of Sustained Release System of Electrospun Poly(acrylic acid)/Dextran Nanofibers Using Emulsion Electrospinning as Wound Dressing Applications.
Meera Moydeen A; Thamer BM; Aldalbahi A; El-Hamshary H; Al-Enizi AM; Syed Ali Padusha M; El-Newehy MH
J Nanosci Nanotechnol; 2021 Mar; 21(3):1613-1622. PubMed ID: 33404425
[TBL] [Abstract][Full Text] [Related]
18. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
[TBL] [Abstract][Full Text] [Related]
19. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes.
Dar MJ; Khalid S; McElroy CA; Satoskar AR; Khan GM
Int J Pharm; 2020 Jan; 573():118900. PubMed ID: 31765786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
